An individual patient data meta-analysis to determine cut-offs for and confounders of NAFLD-fibrosis staging with magnetic resonance elastography
Jia-xu Liang,Javier Ampuero,Hao Niu,Kento Imajo,Mazen Noureddin,Jaideep Behari,Dae Ho Lee,Richard L. Ehman,Fredrik Rorsman,Johan Vessby,Juan R. Lacalle,Ferenc E. Mózes,Michael Pavlides,Quentin M. Anstee,Stephen A. Harrison,Javier Castell,Rohit Loomba,Manuel Romero-Gómez
DOI: https://doi.org/10.1016/j.jhep.2023.04.025
IF: 25.7
2023-04-30
Journal of Hepatology
Abstract:Background & Aims We conducted an individual patient data (IPD) meta-analysis to establish stiffness cut-off values for Magnetic Resonance Elastography (MRE) in staging liver fibrosis and to assess potential confounding factors. Methods A systematic review of the literature identified studies reporting MRE data in patients with non-alcoholic fatty liver disease (NAFLD). Data were obtained from the corresponding authors. Pooled diagnostic cutoff value for the various fibrosis stages was determined in a two-stage meta-analysis. Multilevel modelling methods were used to analyze potential confounding factors influencing diagnostic accuracy of MRE in staging liver fibrosis. Results Eight independent cohorts comprising 798 patients were included in the meta-analysis. The AUROC for MRE in detecting significant fibrosis was 0.92 (sensitivity: 79%, specificity: 89%). For advanced fibrosis, the AUROC was 0.92 (sensitivity: 87%, specificity: 88%). For cirrhosis, the AUROC was 0.94 (sensitivity: 88%, specificity: 89%). Cut-offs were defined to explore concordance between MRE and histopathology: ≥F2: 3.14 kPa (pre-test probability:39.4%); ≥F3: 3.53 kPa (pre-test probability:24.1%); F4: 4.45 kPa (pre-test probability:8.7%). In generalized linear mixed model analysis, histological steatohepatitis with higher inflammatory activity [OR (95% CI) =2.448 (1.180-5.079), P 120U/L) [OR (95% CI) = 3.388(1.577-7.278), P<0.01] were significantly associated with elevated liver stiffness, and thus affecting accuracy in staging early fibrosis (F0–F1). Steatosis, as measured by MRI-PDFF, and body mass index (BMI) were not confounders. Conclusion MRE has excellent diagnostic performance for significant, advanced fibrosis and cirrhosis in patients with NAFLD. Elevated inflammatory activity and GGT level may lead to overestimation in staging early liver fibrosis, but anthropometric measures such as BMI or the degree of steatosis do not. Impact and implications This individual patient data meta-analysis on 8 international cohorts including 798 patients demonstrated that MRE achieves excellent diagnostic accuracy for significant, advanced fibrosis and cirrhosis in patients with NAFLD. The cut-off values (significant fibrosis: 3.14 kPa, advanced fibrosis: 3.53 kPa, cirrhosis: 4.45 kPa) were established. Elevated inflammatory activity and GGT level may affect the diagnostic accuracy of MRE, overestimating liver fibrosis in early stages. No impact of diabetes, obesity or any other metabolic disorder on the diagnostic accuracy of MRE.
gastroenterology & hepatology